Evidence map›Paper›PMID 38318368›Full record

ArticleiScience2024

Embigin deficiency leads to delayed embryonic lung development and high neonatal mortality in mice.

Salli Talvi, Johanna Jokinen, Kalle Sipilä, Pekka Rappu, Fu-Ping Zhang, Matti Poutanen, Pia Rantakari, Jyrki Heino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. A Prognostic Riskscore Model Related toInternational journal of genomics · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Salli TalviDepartment of Life Technologies, University of Turku, 20014 Turku, Finland.
Johanna JokinenDepartment of Life Technologies, University of Turku, 20014 Turku, Finland.
Kalle SipiläDepartment of Life Technologies, University of Turku, 20014 Turku, Finland.
Pekka RappuDepartment of Life Technologies, University of Turku, 20014 Turku, Finland.
Fu-Ping ZhangInstitute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, 20014 Turku, Finland.
Matti PoutanenInFLAMES Research Flagship, University of Turku, 20014 Turku, Finland.
Pia RantakariInFLAMES Research Flagship, University of Turku, 20014 Turku, Finland.
Jyrki HeinoDepartment of Life Technologies, University of Turku, 20014 Turku, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embigin (Gp70), a receptor for fibronectin and an ancillary protein for monocarboxylate transporters, is known to regulate stem cell niches in sebaceous gland and bone marrow. Here, we show that embigin expression is at high level during early mouse embryogenesis and that embigin is essential for lung development. Markedly increased neonatal mortality of Emb

Indexed as

Developmental biologyDevelopmental geneticsTranscriptomics

Identifiers

PMID38318368
PMCPMC10839689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.